Realtime | Geld | Brief | Zeit |
---|---|---|---|
5,338 | 5,513 | 05.10. | |
5,387 | 5,467 | 04.10. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | emeis: 2024 Half-Year Results | 254 | Business Wire | Outlook reaffirmed, acceleration of disposals
A renewed framework and solid fundamentals
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241003728966/en/
emeis... ► Artikel lesen | |
23.09. | XFRA CAPITAL ADJUSTMENT INFORMATION - 23.09.2024 | 455 | Xetra Newsboard | Das Instrument GI11 US36467X2062 GAMING INNOVATION DL 1 EQUITY wird cum Kapitalmassnahme gehandelt am 23.09.2024 und ex Kapitalmassnahme am 24.09.2024 The instrument GI11 US36467X2062 GAMING INNOVATION... ► Artikel lesen | |
03.09. | Orpea appoints Jean-Marc Boursier as CFO | 18 | Seeking Alpha | ||
02.09. | Jean-Marc Boursier Appointed emeis' Chief Financial Officer | 576 | Business Wire | Regulatory News:
emeis (Paris:EMEIS):
Effective 2 September, Jean-Marc Boursier joins Laurent Guillot and his management team as Group Chief Financial Officer (CFO). Jean-Marc will take over... ► Artikel lesen | |
01.08. | emeis: Signature of an Agreement Terminating the Partnerships and Business Relationships Initiated by the Former Management Team With Mr. Tribuno | 445 | Business Wire | Regulatory News:
emeis (Paris:EMEIS) announces that it has reached an agreement with Mr Tribuno terminating their relations which have existed since the beginning of the 2000s as well as those... ► Artikel lesen | |
29.07. | In Accordance With a Commitment Made in 2021, emeis Will Acquire the Buildings of Eight Clinics | 314 | Business Wire | Regulatory News:
emeis (Paris:EMEIS)will buy in 2024 the buildings of 8 clinics which the Company has leased until now, as part of a commitment to buy real estate assets made by the Company during... ► Artikel lesen | |
29.07. | Emeis falls on EBITDAR outlook downgrade | 31 | Reuters | ||
26.07. | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | 573 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
19.07. | emeis: Half-year review (H1 2024) of the liquidity agreement entered into with Natixis ODDO BHF | 372 | Business Wire | Regulatory News:
Under the liquidity agreement entrusted by emeis S.A. (the "Company") (Paris:EMEIS) to Natixis ODDO BHF, the following resources were recorded in the dedicated liquidity account... ► Artikel lesen | |
15.07. | emeis Announces the Signature of a Real Estate Promissory Sales Agreement Concerning Assets in Portugal, worth a Total Value of €24 Million | 430 | Business Wire | A new transaction contributing to the optimisation of capital employed as well as de-leveraging
Regulatory News:
emeis (Paris:EMEIS) announces the signature of a real estate promissory sales... ► Artikel lesen | |
25.06. | emeis 2024 Annual General Meeting, Summary of Voting Results | 601 | Business Wire | Regulatory News:
Orpea (Paris:ORP):
Guillaume Pepy, Chairman of the Board of Directors: "With a renewed shareholder base, a restructured balance sheet and a new identity, we have opened a... ► Artikel lesen | |
03.06. | emeis Sells a Real-Estate Portfolio of Three Nursing Homes in Ireland Worth a Total Value of Around €56 Million | 752 | Business Wire | Regulatory News:
emeis (Paris:ORP) announces that it has signed a sale and lease back agreement on a real estate portfolio of three nursing homes in Ireland with Healthcare Activos for a purchase... ► Artikel lesen | |
17.05. | ORPEA: Documents and Information Related to the Combined General Meeting of 25 June 2024 | 523 | Business Wire | Regulatory News:
The Combined General Meeting (Ordinary and Extraordinary) of Shareholders of ORPEA S.A. (Paris:ORP) (the Company ») will be held on Tuesday 25 June 2024 at 9:30 a.m. (Paris time)... ► Artikel lesen | |
15.05. | Orpea SA reports Q1 results | 15 | Seeking Alpha | ||
14.05. | ORPEA: Solid 11.3% Revenue Growth for emeis in First-quarter 2024 | 633 | Business Wire | ORPEA S.A. quarterly revenue Quarterly revenue growth of 11.3% vs. first-quarter 2023, including 9.6% organic growth
- Solid growth of 6.3% in France
- Strong momentum in international revenue... ► Artikel lesen | |
06.05. | ORPEA S.A.: Filing of the 2023 Universal Registration Document | 401 | Business Wire | Regulatory News:
ORPEA S.A. (the "Company") (Paris:ORP) filed, today, its 2023 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers... ► Artikel lesen | |
30.04. | ORPEA: emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million | 532 | Business Wire | Regulatory News:
ORPEA (Paris:ORP):
emeis announces that it has signed an agreement to sell a real estate portfolio of eleven nursing homes in the Netherlands to Bouwinvest for a total deed-in-hand... ► Artikel lesen | |
17.04. | Orpea SA reports FY results | 24 | Seeking Alpha | ||
17.04. | Emeis edges down as inflation, weak occupancy hit 2023 core profit | 1 | Reuters | ||
17.04. | French care home group Emeis cuts core profit target for 2024 | 1 | Reuters |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,920 | -0,12 % | EQS-News: Formycon AG: Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz) | EQS-News: Formycon AG
/ Schlagwort(e): Zulassungsgenehmigung/Markteinführung
Formycon und Fresenius Kabi erhalten FDA-Zulassung für FYB202/ OtulfiTM (Ustekinumab-aauz)
30.09.2024... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,790 | +0,05 % | Neue 10,50% Aktienanleihe mit Barriere auf Fresenius Medical Care in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC37J41/ WKN VC37J4) mit Barriere auf die Aktie von Fresenius... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,82 | -0,96 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Analyst Falko Friedrichs rechnet in seinem am Montag... ► Artikel lesen | |
CARL ZEISS MEDITEC | 69,05 | +3,14 % | Carl Zeiss Meditec Aktie: Kursanstieg trotz Herausforderungen | Die Carl Zeiss Meditec-Aktie verzeichnete am Handelstag einen leichten Anstieg und schloss bei 71,65 EUR, was einem Zuwachs von 1,1 Prozent entspricht. Trotz des positiven Trends liegt der aktuelle... ► Artikel lesen | |
ECKERT & ZIEGLER | 41,840 | -0,24 % | DAX-Check: Adesso, Adidas, Aroundtown, BMW, Eckert & Ziegler, Gea Group, Renk, Rheinmetall, Traton | In dieser Woche will es bisher noch nicht so richtig laufen für den DAX. Gestern sah es lange Zeit nach Gewinnen aus. Am Nachmittag rutschte der DAX in die Gewinnzone. Heute muss er mit gemischten Vorgaben... ► Artikel lesen | |
DRAEGERWERK | 48,200 | +0,52 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft Draegerwerk auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Drägerwerk mit einem Kursziel von 70 Euro auf "Buy" belassen. Es sei kaum zu bestreiten, dass die Aktien unterbewertet... ► Artikel lesen | |
MEDTRONIC | 80,36 | -0,05 % | Medtronic Recalls MiniMed 600/700 Series Insulin Pumps For Shortened Battery Life | LONDON (dpa-AFX) - Medtronic plc, an Irish healthcare technology company, is recalling its MiniMed 600 series or 700 series insulin pumps citing potential risks of shortened pump battery life.The... ► Artikel lesen | |
INTUITIVE SURGICAL | 438,10 | -0,20 % | Unglaubliche Prognose für Montag setzt Intuitive Surgical Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
TELADOC HEALTH | 8,159 | -1,01 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | PURCHASE, NY, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to three new employees.... ► Artikel lesen | |
GERRESHEIMER | 79,10 | +3,20 % | DAX-Check: Aixtron, Auto1, Covestro, Gerresheimer, Lufthansa, Munich Re, Rheinmetall, Vossloh | Der DAX hat nach der starken Vorwoche gestern eine kleine Verschnaufpause eingelegt. Der deutsche Leitindex rutschte unter die Marke von 19.400 Punkten. Heute scheinen sich die Bullen allerdings bereits... ► Artikel lesen | |
UNITEDHEALTH | 537,70 | -0,15 % | Goelzer Investment Management Inc. Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH) | ||
THERMO FISHER | 544,70 | -0,07 % | Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses | ||
STRATEC | 42,300 | -1,40 % | Stratec-Aktie leicht im Minus (42,35 €) | Im Minus liegt derzeit die Aktie von Stratec . Der jüngste Kurs betrug 42,35 Euro. Die Stratec-Aktie verzeichnet aktuell ein Minus von 2,64 Prozent. Sie hat sich um 1,15 Euro gegenüber dem Schlusskurs... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 72,66 | -2,22 % | Jim Cramer Prefers Intuitive Surgical, Inc. (NASDAQ:ISRG) Over Procept Biorobotics | ||
GENEDX | 49,820 | +5,73 % | GeneDx to Participate in Fall Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:... ► Artikel lesen |